Pancreatic Cancer Research

ResearcherZhejiang Chinese Medical UniversityActive in the last 2 years

Yuhua Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1308-1992; OpenAlex author ID A5075314952. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2025: 2 papers · 2026: 1 paper

Papers 3

  1. Inhibiting calreticulin palmitoylation enhances the efficacy of elesclomol-CuCl2 on oxaliplatin-triggered immunogenic cell death in pancreatic cancer. Last author DOI 10.1016/j.phrs.2026.108459↗
  2. Derazantinib enhances gemcitabine efficacy in PDAC by attenuating the NF-κB and MAPK pathways to suppress MUC5AC expression. Co-author DOI 10.1007/s12032-025-03222-1↗
  3. PreTA-mediated metabolism of 5-fluorouracil by intratumoral Citrobacter freundii drives chemoresistance in pancreatic cancer. Co-author DOI 10.1016/j.celrep.2025.116473↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhimiao Zou · 2 shared papers, 2025–2026 · strength 0.49
  2. Xia Li · 2 shared papers, 2025–2026 · strength 0.49
  3. Wenkai Ye · 1 shared paper, 2025 · strength 0.24
  4. Weiben Xu · 1 shared paper, 2025 · strength 0.21
  5. Xiangyu Jin · 1 shared paper, 2025 · strength 0.21
  6. Luo Fang · 1 shared paper, 2025 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.